New Drug to treat Pancreatic CancerDate: 15 August 2019 Tags: Biotechnology
A new drug has been approved by regulators that can treat Pancreatic Cancer more effectively.
- Pancreatic cancer is particularly known for spreading to distant parts of the body, part of the reason overall five-year survival is just 9 per cent.
- This form of cancer very resistant to chemotherapy drugs mainly due to its ability to form a hard layer that prevents chemo drugs from having its effect on the cells.
Features of Drug
- Radiation and the chemotherapy drug gemcitabine, which are the standard treatment for pancreatic cancer, both work by causing damage to DNA. But pancreatic cancer has a way of repairing that damage, which limits how effective these therapies can be
- AZD1775 prevented pancreatic cancer from protecting itself against the effects of radiation and gemcitabine, while leaving normal cells relatively unaffected.